financetom
Business
financetom
/
Business
/
Rhythm Pharmaceuticals Insider Sold Shares Worth $707,005, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rhythm Pharmaceuticals Insider Sold Shares Worth $707,005, According to a Recent SEC Filing
Mar 22, 2024 1:36 PM

04:21 PM EDT, 03/22/2024 (MT Newswires) -- Jennifer Kayden Lee, Executive Vice President, Head of North America, on March 20, 2024, sold 18,235 shares in Rhythm Pharmaceuticals ( RYTM ) for $707,005. Following the Form 4 filing with the SEC, Lee has control over a total of 6,852 shares of the company, with 6,852 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649904/000110465924037880/xslF345X03/tm249484-1_4seq1.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved